A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment

Journal of Immunological Methods

Volumn 353, Issue 1-2, 2010, Pages 115-123

  Janot Sardet, Caroline ^a   Assouline, Brigitte ^a   Cheynier, Rémi ^b   Morre, Michel ^a   Beq, Stéphanie ^a  

^a Cytheris   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

CD127; ELISA; Interleukin 7; Soluble CD127; TSLP1

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY; SIMIAN VIRUS; VALIDITY; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MACACA FASCICULARIS; MACACA MULATTA; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

MACACA; SIMIAE;

EID: 77649275508     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.12.003     Document Type: Article

References (44)

1. Al-Rawi M.A., Mansel R.E., Jiang W.G. Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours. Histol. Histopathol. 2003, 18:911-923.
2. Armitage R.J., Ziegler S.F., Friend D.J., Park L.S., Fanslow W.C. Identification of a novel low-affinity receptor for human interleukin-7. Blood 1992, 79:1738-1745.
3. Beq S., Rozlan S., Gautier D., Parker R., Mersseman V., Schilte C., Assouline B., Rance I., Lavedan P., Morre M., Cheynier R. Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood 2009, 114:816-825.
4. Blom-Potar M.C., Bugault F., Lambotte O., Delfraissy J.F., Theze J. Soluble IL-7Ralpha (sCD127) and measurement of IL-7 in the plasma of HIV patients. J. Acquir. Immune Defic. Syndr. 2009, 51:104-105.
5. Bogner, M.P., Voss, S.D., Bechhofer, R., Hank, J.A., Roper, M., Poplack, D., Hammond, D. and Sondel, P.M. (1992) Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991) 11, 111.
6. Bolotin E., Smogorzewska M., Smith S., Widmer M., Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996, 88:1887-1894.
7. De Vita F., Turitto G., di Grazia M., Frattolillo A., Catalano G. Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer. Tumori 1998, 84:33-38.
8. DeSilva B., Smith W., Weiner R., Kelley M., Smolec J., Lee B., Khan M., Tacey R., Hill H., Celniker A. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 2003, 20:1885-1900.
9. Esnault S., Rosenthal L.A., Wang D.S., Malter J.S. Thymic stromal lymphopoietin (tslp) as a bridge between infection and atopy. Int. J. Clin. Exp. Pathol. 2008, 1:325-330.
10. Fagerstam L.G., Frostell-Karlsson A., Karlsson R., Persson B., Ronnberg I. Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J. Chromatogr. 1992, 597:397-410.
11. Faucher S., Crawley A.M., Decker W., Sherring A., Bogdanovic D., Ding T., Bergeron M., Angel J.B., Sandstrom P. Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma. PLoS One 2009, 4:e6690.
12. Fry T.J., Mackall C.L. Interleukin-7: master regulator of peripheral T-cell homeostasis? [comment]. Trends Immunol. 2001, 22:564-571.
13. Fry T.J., Christensen B.L., Komschlies K.L., Gress R.E., Mackall C.L. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 2001, 97:1525-1533.
14. Gooding R., Riches P., Dadian G., Moore J., Gore M. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Br. J. Cancer 1995, 72:452-455.
15. Goodwin R.G., Namen A.E. The cloning and characterization of interleukin-7. Year Immunol. 1989, 6:127-139.
16. Grabstein K.H., Waldschmidt T.J., Finkelman F.D., Hess B.W., Alpert A.R., Boiani N.E., Namen A.E., Morrissey P.J. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J. Exp. Med. 1993, 178:257-264.
17. Hanninen E.L., Korfer A., Hadam M., Schneekloth C., Dallmann I., Menzel T., Kirchner H., Poliwoda H., Atzpodien J. Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes. Cancer Res. 1991, 51:6312-6316.
18. Korte A., Kochling J., Badiali L., Eckert C., Andreae J., Geilen W., Kebelmann-Betzing C., Taube T., Wu S., Henze G., Seeger K. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all. Cytokine 2000, 12:1597-1608.
19. Levy Y., Lacabaratz C., Weiss L., Viard J.P., Goujard C., Lelievre J.D., Boue F., Molina J.M., Rouzioux C., Avettand-Fenoel V., Croughs T., Beq S., Thiebaut R., Chene G., Morre M., Delfraissy J.F. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J. Clin. Invest. 2009, 119:997-1007.
20. Ma Y., Hurst H.E., Fernandez-Botran R. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4. J. Pharmacol. Exp. Ther. 1996, 279:340-350.
21. Mackall C.L., Fry T.J., Bare C., Morgan P., Galbraith A., Gress R.E. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001, 97:1491-1497.
22. MacPherson P.A., Fex C., Sanchez-Dardon J., Hawley-Foss N., Angel J.B. Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. JAIDS J. Acquir. Immune Defic. Syndr. 2001, 28:454-457.
23. Nakase K., Kita K., Otsuji A., Anazawa H., Hoshino K., Sekine T., Shirakawa S., Tanaka I., Nasu K., Tsutani H., et al. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells. Br. J. Haematol. 1992, 80:317-326.
24. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., Herndier B.G., Andersson J., McCune J.M. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 2001, 7:73-79.
25. Noguchi M., Nakamura Y., Russell S.M., Ziegler S.F., Tsang M., Cao X., Leonard W.J. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor [see comments]. Science 1993, 262:1877-1880.
26. Park L.S., Friend D.J., Schmierer A.E., Dower S.K., Namen A.E. Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J. Exp. Med. 1990, 171:1073-1089.
27. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 1994, 180:1955-1960.
28. Piscitelli S.C., Forrest A., Vogel S., Chaitt D., Metcalf J., Stevens R., Baseler M., Davey R.T., Kovacs J.A. Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection. Clin. Pharmacol. Ther. 1998, 64:492-498.
29. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 1998, 20:394-397.
30. Reche P.A., Soumelis V., Gorman D.M., Clifford T., Liu M., Travis M., Zurawski S.M., Johnston J., Liu Y.J., Spits H., de Waal Malefyt R., Kastelein R.A., Bazan J.F. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J. Immunol. 2001, 167:336-343.
31. Rethi B., Fluur C., Atlas A., Krzyzowska M., Mowafi F., Grutzmeier S., De Milito A., Bellocco R., Falk K.I., Rajnavolgyi E., Chiodi F. Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. Aids 2005, 19:2077-2086.
32. Rochman Y., Spolski R., Leonard W.J. New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 2009, 9:480-490.
33. Rose T., Lambotte O., Pallier C., Delfraissy J.F., Colle J.H. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J. Immunol. 2009, 182:7389-7397.
34. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000, 1:426-432.
35. Sereti I., Dunham R.M., Spritzler J., Aga E., Proschan M.A., Medvik K., Battaglia C.A., Landay A.L., Pahwa S., Fischl M.A., Asmuth D.M., Tenorio A.R., Altman J.D., Fox L., Moir S., Malaspina A., Morre M., Buffet R., Silvestri G., Lederman M.M. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009, 113:6304-6314.
36. Soares M.V., Borthwick N.J., Maini M.K., Janossy G., Salmon M., Akbar A.N. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J. Immunol. 1998, 161:5909-5917.
37. Sportes C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., Fleisher T.A., Krumlauf M.C., Babb R.R., Chow C.K., Fry T.J., Engels J., Buffet R., Morre M., Amato R.J., Venzon D.J., Korngold R., Pecora A., Gress R.E., Mackall C.L. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 2008, 205:1701-1714.
38. Uckun F.M., Dibirdik I., Smith R., Tuel-Ahlgren L., Chandan-Langlie M., Schieven G.L., Waddick K.G., Hanson M., Ledbetter J.A. Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:3589-3593.
39. Uckun F.M., Tuel-Ahlgren L., Obuz V., Smith R., Dibirdik I., Hanson M., Langlie M.C., Ledbetter J.A. Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:6323-6327.
40. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 1995, 181:1519-1526.
41. Vranjkovic A., Crawley A.M., Gee K., Kumar A., Angel J.B. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int. Immunol. 2007, 19:1329-1339.
42. Webb L.M., Foxwell B.M., Feldmann M. Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ T-cell pool. Immunology 1999, 98:400-405.
43. Yamaguchi K., Nishimura Y., Kiyokawa T., Matsuzaki H., Ishii T., Kubota K., Kawahara M., Furuse K., Yoshinaga T., Kinuwaki E., et al. Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma. J. Lab. Clin. Med. 1990, 116:457-461.
44. Zorn U., Dallmann I., Grosse J., Kirchner H., Poliwoda H., Atzpodien J. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells. Cytokine 1994, 6:358-364.